
A clear and workable medication plan is an essential part of the transition home.
Valbenazine (Ingrezza) is indicated for the treatment of adults with tardive dyskinesia.
Medication Pearl of the Day: Valbenazine (Ingrezza)
Indication: Valbenazine (Ingrezza) is a vesicular monoamine transporter 2 (VMAT2) inhibitor indicated for the treatment of adults with tardive dyskinesia.
Insight:




